225 related articles for article (PubMed ID: 23960239)
1. The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis.
Naves R; Singh SP; Cashman KS; Rowse AL; Axtell RC; Steinman L; Mountz JD; Steele C; De Sarno P; Raman C
J Immunol; 2013 Sep; 191(6):2967-77. PubMed ID: 23960239
[TBL] [Abstract][Full Text] [Related]
2. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
3. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
[TBL] [Abstract][Full Text] [Related]
4. Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages.
Dungan LS; McGuinness NC; Boon L; Lynch MA; Mills KH
Eur J Immunol; 2014 Oct; 44(10):2903-17. PubMed ID: 25056715
[TBL] [Abstract][Full Text] [Related]
5. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
Oh SJ; Chung DH
J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
[TBL] [Abstract][Full Text] [Related]
6. Lithium controls central nervous system autoimmunity through modulation of IFN-γ signaling.
Rowse AL; Naves R; Cashman KS; McGuire DJ; Mbana T; Raman C; De Sarno P
PLoS One; 2012; 7(12):e52658. PubMed ID: 23285134
[TBL] [Abstract][Full Text] [Related]
7. Interferon-γ orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis.
Berghmans N; Nuyts A; Uyttenhove C; Van Snick J; Opdenakker G; Heremans H
J Interferon Cytokine Res; 2011 Jul; 31(7):575-87. PubMed ID: 21348780
[TBL] [Abstract][Full Text] [Related]
8. Regulation of IL-10 and IL-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione.
Singh I; Nath N; Saxena N; Singh AK; Won JS
Immunobiology; 2018 Oct; 223(10):549-554. PubMed ID: 29960806
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 signaling in glial cells ameliorates experimental autoimmune encephalomyelitis by restraining the generation of a pro-Th17 cytokine milieu and reducing CNS-infiltrating Th17 cells.
Chung CY; Liao F
J Neuroinflammation; 2016 Apr; 13(1):76. PubMed ID: 27068264
[TBL] [Abstract][Full Text] [Related]
10. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis.
Lees JR; Golumbek PT; Sim J; Dorsey D; Russell JH
J Exp Med; 2008 Oct; 205(11):2633-42. PubMed ID: 18852291
[TBL] [Abstract][Full Text] [Related]
11. Sema4A is implicated in the acceleration of Th17 cell-mediated neuroinflammation in the effector phase.
Koda T; Namba A; Kinoshita M; Nakatsuji Y; Sugimoto T; Sakakibara K; Tada S; Shimizu M; Yamashita K; Takata K; Ishikura T; Murata S; Beppu S; Kumanogoh A; Mochizuki H; Okuno T
J Neuroinflammation; 2020 Mar; 17(1):82. PubMed ID: 32169103
[TBL] [Abstract][Full Text] [Related]
12. Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity.
Ding X; Yan Y; Li X; Li K; Ciric B; Yang J; Zhang Y; Wu S; Xu H; Chen W; Lovett-Racke AE; Zhang GX; Rostami A
J Immunol; 2015 May; 194(9):4251-64. PubMed ID: 25795755
[TBL] [Abstract][Full Text] [Related]
13. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.
Ponomarev ED; Novikova M; Yassai M; Szczepanik M; Gorski J; Dittel BN
J Immunol; 2004 Aug; 173(3):1587-95. PubMed ID: 15265886
[TBL] [Abstract][Full Text] [Related]
14. Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation.
Zhang L; Yuan S; Cheng G; Guo B
PLoS One; 2011; 6(12):e28432. PubMed ID: 22163016
[TBL] [Abstract][Full Text] [Related]
15. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.
Teige I; Treschow A; Teige A; Mattsson R; Navikas V; Leanderson T; Holmdahl R; Issazadeh-Navikas S
J Immunol; 2003 May; 170(9):4776-84. PubMed ID: 12707359
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.
Herges K; de Jong BA; Kolkowitz I; Dunn C; Mandelbaum G; Ko RM; Maini A; Han MH; Killestein J; Polman C; Goodyear AL; Dunn J; Steinman L; Axtell RC
Mult Scler; 2012 Apr; 18(4):398-408. PubMed ID: 22343184
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
Sosa RA; Murphey C; Robinson RR; Forsthuber TG
Proc Natl Acad Sci U S A; 2015 Sep; 112(36):E5038-47. PubMed ID: 26305941
[TBL] [Abstract][Full Text] [Related]
18. TGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE.
Huss DJ; Winger RC; Cox GM; Guerau-de-Arellano M; Yang Y; Racke MK; Lovett-Racke AE
Eur J Immunol; 2011 Oct; 41(10):2987-96. PubMed ID: 21728174
[TBL] [Abstract][Full Text] [Related]
19. Independent and interdependent immunoregulatory effects of IL-27, IFN-β, and IL-10 in the suppression of human Th17 cells and murine experimental autoimmune encephalomyelitis.
Fitzgerald DC; Fonseca-Kelly Z; Cullimore ML; Safabakhsh P; Saris CJ; Zhang GX; Rostami A
J Immunol; 2013 Apr; 190(7):3225-34. PubMed ID: 23455508
[TBL] [Abstract][Full Text] [Related]
20. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
